( Figure 1A) . At 4 weeks, bladders were harvested and weighed and correlation of raw data was assessed with 4-week ( Figure 1B ) and 1-week ( Figure 1C ) mVVs. 1-week mVV data was further evaluated through bivariate kernel density estimation and a Pearson correlation coefficient (SAS). Single variable histogram of the data established groups based on BWs and mVV. mVVs and bladder weights within group pairings were averaged and plotted to render a non-linear regression model. RESULTS: A significant correlation was found between 1-week mVVs and 4-week BWs upon bivariate analysis with a correlation coefficient of -0.758 (p[0.0294) ( Figure 1D) . A non-linear regression of plotted data defined a statistically significant fit equation correlating 1-week mVV to 4-week BW.
INTRODUCTION AND OBJECTIVES:
Medicaid expansion is a key provision by which the Affordable Care Act seeks to improve access to health insurance. However, there is concern over the quality and cost of care received by Medicaid beneficiaries. Urinary stone disease is a condition uniquely suited to address the aforementioned quality/cost concerns: the disease incurs high population-level costs with multiple treatment options and large variation in practice and care setting. We investigated the role of payer status in predicting perioperative outcomes and cost associated with elective definitive surgery for nephroureterolithiasis.
METHODS: All-payer data from the 2014 Healthcare Cost and Utilization Project (HCUP) State Databases from Florida (FL) and New York (NY) were used to identify all index elective definitive surgical interventions for nephroureterolithiasis in the form of ureteroscopy (URS) or shockwave lithotripsy (SWL). Patient demographics, regional data, 30-day revisit rates, and total charges (converted to costs) were determined. Multivariate logistic regression adjusted for facility clustering was utilized to identify predictors of index care setting.
RESULTS: We identified a total of 27,527 unique patients undergoing either an elective index URS (n[16,572) 
PD01-02 ECONOMIC EVALUATION OF STENTLESS VS. STENTED URETEROSCOPY AND LASER LITHOTRIPSY
Tammer Yamany*, Michal Ursiny, Brian Eisner, Boston, MA INTRODUCTION AND OBJECTIVES: Current guidelines suggest ureteral stent placement may be omitted in select patients. Complication and re-operative rates are known to be higher for stentless ureteroscopy (URS). The purpose of this study is to assess the cost-effectiveness of stentless vs stented URS laser lithotripsy using a decision analysis model. METHODS: Expected value calculations with Markov modeling and sensitivity analysis were used to determine the optimal method based on overall cost-effectiveness inclusive of equipment, time, secondary costs from complications, emergency department visits, hospital readmission, and re-interventions. Data from randomized controlled trials and meta-analyses comparing stent placement and stent omission after routine URS laser lithotripsy were utilized to determine rates of emergency department visits, readmissions, reinterventions and practice patterns among urologists. Cost of operating room disposables were obtained from manufacturers. Costs of emergency department visits, readmissions, immediate and delayed re-interventions were calculated based on published figures from the literature. Costs for billable procedures were determined using published data.
RESULTS: Decision analysis modeling demonstrated that on a per-procedure basis, URS laser lithotripsy with and without ureteral stenting had average costs of $11,268 and $8,328, respectively
